Cancer glossary
Palbociclib, ribociclib, abemaciclib: CDK4/6 inhibitors for breast cancer
CDK4/6 inhibitors are tablets that strengthen hormone therapy. Who gets them, how the three drugs differ, which tests are needed and which side effects occur.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Palbociclib, ribociclib and abemaciclib are tablets that block CDK4 and CDK6, proteins a cell needs to divide. They are given together with hormone therapy for breast cancer that is hormone receptor-positive and HER2-negative.
How it appears in your prescription
- ‘Palbociclib 125 mg for 21 days, 7 days off + letrozole’.
- ‘Ribociclib 600 mg 21/7 + fulvestrant’.
- ‘Abemaciclib 150 mg twice a day continuously + aromatase inhibitor’ — including after surgery when risk is high.
What it means
According to the US National Cancer Institute, CDK4/6 inhibitors together with aromatase inhibitors or fulvestrant are standard treatment for metastatic hormone receptor-positive, HER2-negative breast cancer: they clearly extend the time without progression. Abemaciclib and ribociclib are also used after surgery in patients at high risk of recurrence.
Side effects
They differ by drug:
| Drug | Most common | What is monitored |
|---|---|---|
| Palbociclib | low neutrophils, fatigue | complete blood count |
| Ribociclib | low neutrophils, liver test changes | blood, liver, ECG (QT interval) |
| Abemaciclib | diarrhea, fatigue | blood, liver; diarrhea treated straight away |
Questions to ask your doctor
- Which drug, and why that one?
- Which tests, and how often, in the first months?
- What should I do about diarrhea or a fever?
Sources
- Palbociclib — National Cancer Institute
- Ribociclib — National Cancer Institute
- Abemaciclib — National Cancer Institute
- Hormone Therapy for Breast Cancer — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
